Common Shares

Common Shares

Common Shares

The units are subject to exchange or redemption pursuant to the terms of the LLLP Agreement and the applicable redemption plan.

These derivative securities do not have an expiration date.

The Reporting Person has an ownership interest in JKD, Inc.

The reporting person received the Limited Partnership Units in connection with a 721 UPREIT Transaction

Michael P. Carlson, as Attorney-in-Fact for Kenneth P. Regan pursuant to Power of Attorney previously filed


Common Stock

25,000 of the stock options vest on date of grant and 25,000 vest on August 4, 2026.


Class A Common Stock

Each phantom stock unit is the economic equivalent of one share of Class A Common Stock of Greif, Inc.

The phantom shares are to be settled in cash upon the Reporting Person's termination from the Board due to her retirement, death or other reason.

Karen A. Morrison by L. Dennis Hoffman, Jr. pursuant to a POA filed with the Commission.


Class A Common Stock

The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction.

Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock.

On August 4, 2023, the reporting person was granted 127,875 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date.

Patrick C. Cannon, attorney-in-fact for Carl M. Fisher


Common Stock

45,000 of the stock options vest on date of grant and 45,000 vest on August 4, 2026.


Represents "sell to cover" sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on September 11, 2024 to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

Represents RSUs granted to the filing person on September 20, 2024. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 8.33% will vest on November 1, 2025, and each three-month anniversary thereafter, subject to the filing person's continued employment with Chewy, Inc. through the applicable vesting date.

Represents RSUs granted to the filing person on September 20, 2024. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 58.5% will vest on August 1, 2026, and 41.5% will vest on August 1, 2027, subject to the filing person's continued employment with Chewy, Inc. through the applicable vesting date.

Represents RSUs granted to the filing person on April 8, 2025. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 25% of these RSUs will vest on March 1, 2026, and 6.25% will vest on each three-month anniversary thereafter, subject to the filing person's continued employment with Chewy, Inc. through the applicable vesting date

/s/ Da-Wai Hu, as Attorney-in-fact- for William G. Billings


Common Stock, par value $0.001 per share ("Common Stock")

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at a price of $5.50 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares bought at each price.

Represents securities owned directly by Mink Brook Partners LP (the "Fund"). As the investment manager of the Fund, Mink Brook Asset Management LLC may be deemed to beneficially own the securities owned directly by the Fund.

Mink Brook Asset Management LLC, and the general partner for both funds, Mink Brook Capital GP LLC, disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Mink Brook Asset Management LLC, Mink Brook Capital GP LLC or William Mueller as managing member of both, is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Represents securities owned directly by Mink Brook Opportunity Fund LP (the "Fund"). As the investment manager of the Fund, Mink Brook Asset Management LLC may be deemed to beneficially own the securities owned directly by the Fund.


Represents "sell to cover" sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on April 15, 2022 to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on April 9, 2025.

Represents performance-based restricted stock units ("PRSUs") granted to the filing person. Each PRSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The PRSUs were initially granted on April 6, 2023 and the amount of PRSUs eligible for vesting was subject to certification of the satisfaction of certain performance conditions for the 2023 fiscal year by the Compensation Committee of the Board of Directors. On March 22, 2024, the Compensation Committee of the Board of Directors certified the achievement of the performance conditions for the PRSUs, which vest on February 1, 2026, subject to the filing person's continued employment with Chewy, Inc. through the vesting date.

Represents RSUs granted to the filing person on April 6, 2023. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. With respect to 20,292 of the RSUs, 33.33% will vest on February 1, 2026 and 33.33% will vest on each six-month anniversary thereafter, subject to the filing person's continued employment with Chewy, Inc. through the applicable vesting date. With respect to 6,764 of the RSUs, 100% will vest on February 1, 2026, subject to the filing person's continued employment with Chewy, Inc. through the vesting date.

Represents PRSUs granted to the filing person. Each PRSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The PRSUs were initially granted on April 4, 2024 and the amount of PRSUs eligible for vesting was subject to certification of the satisfaction of certain performance conditions for the 2024 fiscal year by the Compensation Committee of the Board of Directors. On March 26, 2025, the Compensation Committee of the Board of Directors certified the achievement of the performance conditions for the PRSUs, which vest on February 1, 2027, subject to the filing person's continued employment with Chewy, Inc. through the vesting date.

Represents RSUs granted to the filing person on April 4, 2024. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 8.41% will vest on November 1, 2025, 15.84% will vest on December 1, 2025, and 8.41% will vest on February 1, 2026 and on each three-month anniversary thereafter, subject to the filing person's continued employment with Chewy, Inc. through the applicable vesting date.

Represents RSUs granted to the filing person on April 8, 2025. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 25% of these RSUs will vest on March 1, 2026, and 6.25% will vest on each three-month anniversary thereafter, subject to the filing person's continued employment with Chewy, Inc. through the applicable vesting date.

/s/ Da-Wai Hu, as Attorney-in-Fact for Satish Mehta


The reported transaction represents the acquisition of 10 shares in connection with the issuer's acquisition of Discover Financial Services ("Discover") on May 18, 2025. Pursuant to the merger
agreement, each issued and outstanding share of Discover common stock held by the reporting person was converted into the right to receive 1.0192 shares of Capital One common stock. All fractional
share holdings were paid in cash. The acquisition of these shares was exempt from prior reporting under Rule 16a-6.


The sale transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024.

The sale price represents the weighted average price of the shares sold ranging from $130.61 to $131.53 per share. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

The sale price represents the weighted average price of the shares sold ranging from $131.88 to $132.85 per share. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

The sale price represents the weighted average price of the shares sold ranging from $133.30 to $134.11 per share. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

/s/ Bruce Posey by power of attorney for Joo Mi Kim


/s/ Craig L. Rosenthal, Attorney in Fact


The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025.  The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.86 to $2.93, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

/s/Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso


Reflects a bona fide charitable gift of 900 shares of AZZ Inc. common stock by the Reporting Person that was donated to his church in support of its capital campaign.

/s/ Tara D. Mackey, attorney-in-fact for Daniel E. Berce


Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Voluntary Equity Investment Program.

/s/ Danika Haueisen, Attorney-in-Fact for Joel Unruch


/s/ Danika Haueisen, Attorney-In-Fact for Manish Sharma


/s/ Danika Haueisen, Attorney-in-Fact for John F. Walsh


Ordinary Shares - Restricted Stock Units

Ordinary  Shares

Ordinary Shares

End-of-period holdings include monthly purchases under the nVent Electric plc Employee Stock Purchase Plan (ESPP) in exempt transactions pursuant to Rule 16b-3(c).

The price in Column 4 is a weighted average price. The prices actually received ranged from $89.475 to $89.52. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.

End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a).

Shares of nVent Electric plc will be delivered to the reporting person in accordance with their irrevocable deferral election.

This option is presently exercisable in full.

/s/ John K. Wilson, Attorney-in-Fact for Sara E. Zawoyski


Agiri Oluwagbemileke Yusuf

C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH

Represents shares sold by the Reporting Person to cover tax withholding obligations upon vesting of a restricted stock award. The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 22, 2024.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.21 to $1.28 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Between June 9, 2025 and August 5, 2025, the reporting person disposed of 14.93 shares of the issuer's common stock under the issuer's 401(k) plan to cover administrative fees. The information in this report is based on a plan statement dated July 25, 2025.


/s/ Danika Haueisen, Attorney-In-Fact for Julie Spellman Sweet


Non-qualified Stock Option (Right to Buy)

Common Stock

As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2025.

Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $247.2000 to $248.1100 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $248.5499 to $249.5441 inclusive.  The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $249.5568 to $250.5092 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $250.6220 to $251.5245 inclusive.  The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $251.7051 to $252.1941 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Shares held in the Marc Benioff Fund LLC (the "Fund").  Fund interests are held in the reporting person's name or in trust.

Option vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

/s/ Andrew Leeds, Attorney-in-Fact for Marc Benioff


Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Voluntary Equity Investment Program.

/s/ Danika Haueisen, Attorney-in-Fact for Melissa A. Burgum


/s/ Danika Haueisen, Attorney in- Fact for Angie Y. Park


Common Stock

The restricted stock unit vested as to 25% of the shares subject to such award on August 4, 2022. The remaining 75% of the shares subject to such award vests in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter.

Not applicable for Restricted Stock Units.

/s/ John G. Saia, as attorney-in-fact for Meghan Verena Joyce


Reflects shares held by the BHJH Master Trust LLC.  By virtue of his position as chief investment adviser of BHJH Master Trust, Bernardo Hees may be deemed to be a beneficial owner of the securities listed.

Price reflects the weighted average sale price for the sale transactions made on the date reported above. Sale prices ranged from $160.25 to $160.31. The reporting person will provide, upon request by the Staff, the Company, or a security holder of the Company, full information regarding the number of shares purchased or sold at each separate price.

/s/ Jean M. Sera, by Power of Attorney for Bernardo Hees


Represents shares sold by the Reporting Person to cover tax withholding obligations upon vesting of a restricted stock award. The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2024.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.21 to $1.28 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


Represents a weighted average purchase price per share. These shares were purchased in multiple transactions at prices ranging from $30.74 to $30.87. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.

These shares are held directly by the Trust of which the Reporting Person serves as a trustee.

Balance includes a non-reportable acquisition of 420 shares purchased through the Enphase Erergy, Inc. 2011 Employee Stock Purchase Plan on May 15, 2025.

/s/ Lisan Hung, Attorney-in-Fact for Badri Kothandaraman


Common Stock

Restricted Stock Units (RSUs) granted under the Issuer's Incentive Plan. Each RSU represents the right to receive one share of the Issuer's common stock on August 5, 2028, provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as provided in such Plan.


Represents shares sold by the Reporting Person to cover tax withholding obligations upon vesting of a restricted stock award. The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024.


Includes shares purchased under the Issuer's Buy As You Earn and Save As Your Earn plans.

/s/ Lisa Kish, by Power of Attorney for Georgina Fogo


Represents shares sold by the Reporting Person to cover tax withholding obligations upon vesting of a restricted stock award. The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 25, 2024.


Common Stock

The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025.

The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $68.45 to $68.5563, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Fully vested.

Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person.

Robert F. Probst, By: /s/ Kenneth Hagan, Attorney-In-Fact


Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

End-of-period holdings include monthly purchases under the nVent Electric plc Employee Stock Purchase Plan (ESPP) in exempt transactions pursuant to Rule 16b-3(c).

Shares swapped to cover the stock option exercise prices resulting from the stock option exercises.

The price in Column 4 is a weighted average price. The prices actually received ranged from $89.231 to $89.40. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.

End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a).

Shares of nVent Electric plc will be delivered to the reporting person in accordance with their irrevocable deferral election.

This option is presently exercisable in full.

/s/ John K. Wilson, Attorney-in-Fact for Lynnette R. Heath


This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2024.

This transaction was executed in multiple trades during the day at prices ranging from $97.41 to $106.62. The weighted-average price is reported above. The Reporting Person hereby undertakes to
provide to the SEC staff, the Issuer, or any security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the trades were made.

/s/ Matthew Yorkavich, attorney-in-fact for Daniel M. Gallagher, Jr.


This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 12, 2025.

This transaction was executed in multiple trades during the day at prices ranging from $185.19 to $186.17. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Shares are held by Farquhar Investment Partnership No. 2.

This transaction was executed in multiple trades during the day at prices ranging from $183.18 to $184.17. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $184.18 to $185.16. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $186.21 to $186.40. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

/s/ Veena Bhatia, Attorney-in-Fact for Farquhar Scott


This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2025.

Shares are held by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.

/s/ Veena Bhatia, Attorney-in-Fact for Cannon-Brookes Michael


Represents shares sold by the Reporting Person to cover tax withholding obligations upon vesting of a restricted stock award. The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024.


Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

The price in Column 4 is a weighted average price. The prices actually received ranged from $89.255 to $89.67. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.

The price in Column 4 is a weighted average price. The prices actually received ranged from $89.315 to $89.67. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.

The price in Column 4 is a weighted average price. The prices actually received ranged from $89.61 to $89.67. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.

The price in Column 4 is a weighted average price. The prices actually received ranged from $89.22 to $89.385. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.

End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a).

This option is presently exercisable in full.

One-third of the stock options become exercisable on the first, second and third anniversary of March 5, 2023.

One-third of the stock options become exercisable on the first, second and third anniversary of March 5, 2024.

/s/ John K. Wilson, Attorney-in-Fact for Jon D. Lammers


Represents shares sold by the Reporting Person to cover tax withholding obligations upon vesting of a restricted stock award. The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 14, 2024.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.21 to $1.28 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


Common Stock

Each restricted stock unit (RSU) is granted pursuant to Babcock & Wilcox Enterprises, Inc. Amended and Restated Long-Term 2021 Incentive Plan and represents a contingent right to receive one share of BW common stock.

RSUs vest in three annual installments beginning August 5, 2025.

/s/ John J. Dziewsiz, attorney-in-fact for Christopher S. Riker


Includes shares acquired through dividend reinvestment plan

Shares inherited from father


THIS FORM 4 CONCERNS THE VESTING AND SETTLEMENT OF RESTRICTED STOCK UNITS ("RSUs"), WHICH SERVE TO INCREASE THE NUMBER OF SHARES OF THE OUTSTANDING CAPITAL STOCK OF THE ISSUER OWNED BY THE REPORTING PERSON, AND THE RELATED SALE OF CERTAIN SHARES REQUIRED PURSUANT TO A 10B5-1 INSTRUCTION LETTER TO SATISFY THE TAX OBLIGATIONS OWED IN CONNECTION WITH THE VESTING AND SETTLEMENT OF SUCH RSUs. SEE ADDITIONAL FOOTNOTES BELOW FOR MORE INFORMATION.

REPRESENTS THE AGGREGATE NUMBER OF SHARES SOLD BY THE REPORTING PERSON SOLELY TO COVER REQUIRED TAXES AND FEES DUE UPON THE VESTING AND SETTLEMENT OF RSUs. THE SALES WERE MADE PURSUANT TO A 10B5-1 INSTRUCTION LETTER DELIVERED TO THE ISSUER ON AUGUST 13, 2024, AND NONE OF THE SHARES REPORTED ON THIS FORM 4 WERE SOLD FOR ANY REASON OTHER THAN TO COVER REQUIRED TAXES AND FEES.

793,621 of these securities are RSUs, each representing a contingent right to receive one share of the Issuer's Class A Common Stock.

/s/ Danielle Warner as Attorney-in-Fact for Sarah Oughtred


Price is the volume weighted average purchase price of all purchases by the Reporting Person on the transaction date within a one-dollar range.  Actual prices ranged from $155.00 to $155.98.  The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares purchased at each separate price.

Price is the volume weighted average purchase price of all purchases by the Reporting Person on the transaction date within a one-dollar range.  Actual prices ranged from $156.01 to $156.94.  The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares purchased at each separate price.

The shares vest as follows: 5,337 shares on March 1, 2026; 3,632 shares on March 1, 2027; and 2,082 shares on March 1, 2028. The remaining shares are vested.

Jeff D. Barlow, by power of attorney for James Woys


The price in Column 4 is a weighted average price. The prices actually received ranged from $89.66 to $90.07. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares
sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.

/s/ John K. Wilson, Attorney-in-Fact for Herbert K. Parker


/s/ Christian P. Callens, by Power of Attorney


ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/

This transaction was executed in multiple trades at prices ranging from $52.32 to $52.35. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.


These shares were sold to cover tax withholding due upon vesting of RSUs. Such "sales to cover" are mandated by the Issuer's equity incentive plans to satisfy tax withholding obligations and do not represent a discretionary trade by the reporting person.

/s/ Jeanette Sellers, Attorney-in-Fact for April Rieger


By Arete Trust, John Kent Walker and Diana Ruth Walsh, Trustees

Class C Google Stock Units (GSUs) entitle the Reporting Person to receive one share of Alphabet Inc. Class C capital stock for each share underlying the GSUs as each GSU vests. 1/6th of the GSUs vested on June 25, 2023 and an additional 1/12th of the GSUs vests quarterly thereafter until the GSUs are fully vested, subject to continuing employment on the applicable vesting dates.

1/6th of the GSUs vested on June 25, 2024; 1/12th of the GSUs vested on September 25, 2024, and an additional 1/12th of the GSUs vests quarterly thereafter on the 25th day of the month until the GSUs are fully vested, subject to continued employment on the applicable vesting dates.

The GSUs vest as follows: (i) 27/260th of the grant will vest on each March 25, 2025, June 25, 2025, September 25, 2025 and December 25, 2025; and (ii) 19/260th of the grant will vest quarterly on the 25th day of the month from March 25, 2026 through December 25, 2026, and on the 1st day of the month from April 1, 2027 through January 1, 2028, subject to continued employment on the applicable vesting dates.

Transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person as Trustee of The Arete Trust on May 29, 2024.

/s/ Valentina Margulis, as Attorney-in-Fact for John Kent Walker


Ordinary Shares

End-of-period holdings include monthly purchases under the nVent Electric plc Employee Stock Purchase Plan (ESPP) in exempt transactions pursuant to Rule 16b-3(c).

End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a).

This option is presently exercisable in full.

/s/ John K. Wilson, Attorney-in-Fact for Robert J. van der Kolk


Represents restricted stock units granted on August 5, 2025, which vest in four equal annual installments over four years with a vesting commencement date of October 1, 2025.

/s/ Cesare Suardi, Attorney-in-Fact for Sean Dougherty


Common Stock

Each share of phantom stock represents a right to receive the cash value of one share of the Company's common stock.

Shares of phantom stock are payable in cash following the reporting person's separation from service with the Company.

Includes shares acquired through dividend reinvestment.

/s/ Jeffrey J. Pochowicz, Attorney-in-fact


Represents the distribution of shares of common stock to members of BG Lineage Holdings, LLC in accordance with their respective pecuniary interests, for no consideration.

/s/ Kristina Hentschel, as Attorney-in-Fact, for BG Lineage Holdings, LLC


By the Brian R. Elworthy Irrevocable Trust of 2019

Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs, and does not represent a discretionary trade by the Reporting Person.

/s/ Xing Yan as Attorney-in-Fact for Brian R. Elworthy


As of the date of this Form 4, the Reporting Person also owns an aggregate of 25,722,670 shares of the Class B common stock of the Issuer. Each share of Class B common stock is convertible at any time into one share of the Class A common stock of the Issuer.

/s/ Xing Yan as Attorney-in-Fact for Stephen Fredette


/s/ Xing Yan as Attorney-in-Fact for Elena Gomez


/s/ Jeanette Sellers, Attorney-in-fact for Gregory Orenstein


/s/ Xing Yan as Attorney-in-Fact for Jonathan Vassil


As of the date of this Form 4, the Reporting Person also owns 18,912,840 shares of Class B common stock of the Issuer. Each Class B common stock is convertible at any time into one share of the Class A common stock of the Issuer.

/s/ Xing Yan as Attorney-in-Fact for Aman Narang


Weighted average price. Actual prices ranged from $45.29 to $45.35. Full information regarding the number of shares sold at each separate price will be provided upon request to the SEC's staff, Insperity, Inc. or its stockholders.


Common Stock

Represents restricted stock units of the Issuer issued pursuant to the Hilton 2017 Omnibus Incentive Plan, which vest in two equal annual installments beginning on August 5, 2026.

Represents restricted stock units of the Issuer issued pursuant to the Hilton 2017 Omnibus Incentive Plan, which vest in four equal annual installments beginning on August 5, 2026.

The option vests in three equal annual installments beginning on August 5, 2026.

Executive Vice President and Chief Development Officer


These shares were sold to cover tax withholding due upon vesting of RSUs. Such "sales to cover" are mandated by the Issuer's equity incentive plans to satisfy tax withholding obligations and do not represent a discretionary trade by the reporting person.

/s/ Jeanette Sellers, Attorney-in-Fact for Pierre Naude


Common Stock

Stock granted in lieu of cash for portion of board fees

Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

On July 25, 2025, the Issuer effected a reverse stock split of Issuer Common Stock at a ratio of 1-for-15 (the "Reverse Stock Split"). As a result of the Reverse Stock Split, the shares of Issuer Common Stock, and the exercise price and shares of Issuer Common Stock underlying outstanding equity awards, have been adjusted accordingly versus any amounts previously reported by the Reporting Person.

/s/ Susan Eylward, Attorney-in-Fact for James E. Dentzer


Following all the transactions reported on this Form 4, the reporting person holds 16,376 shares directly.


Includes 748 shares acquired under the Issuer's stock purchase plan on June 30, 2025.

/s/ Jeanette Sellers, Attorney-in-fact for Sean Desmond


The shares of the Issuer's Class A Common Stock were withheld for tax withholding purposes in connection with the vesting of 29,051 shares under a restricted stock unit award granted on August 5, 2024

Includes 29,376 shares of restricted stock units vesting in two substantially equal annual installments beginning on August 5, 2026 and 7,560 shares of restricted stock vesting in four substantially equal annual installments beginning on November 6, 2025, each subject to the reporting person's continued employment through each applicable vesting date.

STEVE D. MENNETO, /S/ Brooke Zinter as attorney-in-fact


The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.


Common Stock

/s/ Susan Eylward, Attorney-in-Fact for Christine Pellizzari


Common Stock

Represents shares of common stock withheld by the Issuer pursuant to the terms of the award to pay tax withholding obligations of the Reporting Person upon the vesting of the RSUs.

Each restricted stock unit (RSU) is granted pursuant to Babcock & Wilcox Enterprises, Inc. Amended and Restated Long-Term 2021 Incentive Plan and represents a contingent right to receive one share of BW common stock.

RSUs vest in three annual installments beginning August 5, 2025.

/s/ John J. Dziewisz, attorney-in-fact for Jimmy B. Morgan


Weighted average price. Actual prices ranged from $46.77 to $46.89. Full information regarding the number of shares sold at each separate price will be provided upon request to the SEC's staff, Insperity, Inc. or its stockholders.

/s/ Christian P. Callens, by Power of Attorney


The sales were executed in multiple trades at prices ranging from $53.85-$54.83. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.

The sales were executed in multiple trades at prices ranging from $54.87-$55.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.

Following all the transactions reported on this Form 4, the reporting person holds 1,183,134 shares directly.

Following all the transactions reported on this Form 4, the reporting person holds 12,888 shares indirectly through the issuer's 401(k) plan as of August 6, 2025, which changed from the prior Form 4 by 10 shares due to an administrative correction.


Common Stock

/s/ Susan Eylward, Attorney-in-Fact for Donald P. Braun


Common Stock


Common Stock

Stock granted in lieu of cash for portion of board fees.

/s/ Susan Eylward, Attorney-in-Fact for Frederick J. Fritz


Common Stock

Common Stock

Represents shares of common stock withheld by the Issuer pursuant to the terms of the award to pay tax withholding obligations of the Reporting Person upon the vesting of the restricted stock units.

RSUs vest in three installments beginning August 4, 2024.

RSUs vest in three installments beginning August 5, 2025.

/s/ John J. Dziewisz, Attorney-in-Fact for Cameron M. Frymyer


The purchases reported herein were effected pursuant to a Rule 10b5-1 plan adopted by Hill City Holdings, LP ("Hill City") on June 5, 2025.

The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $12.62 to $13.16. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The securities are held of record by Hill City. ECP ControlCo, LLC is the managing member of Energy Capital Partners IV, LLC, which is the general partner of Energy Capital Partners GP IV, LP, which is the general partner of each of (i) Energy Capital Partners IV-A, LP, (ii) Energy Capital Partners IV-B, LP, (iii) Energy Capital Partners IV-C, LP, and (iv) Energy Capital Partners IV-D, LP (the "Funds"). Energy Capital Partners GP IV, LP is also the general partner of Energy Capital Partners IV-B (Hill City IP), LP ("Hill City IP"). Each of (i) Energy Capital Partners IV-A, LP, (ii) Hill City IP, (iii) Energy Capital Partners IV-C, LP, and (iv) Energy Capital Partners IV-D, LP are the members of Hill City Holdings GP, LLC, which is the general partner of Hill City.

ECP ControlCo, LLC is controlled by its board of managers, which consists of Douglas Kimmelman, Peter Labbat, Tyler Reeder, Rahman D'Argenio, Raoul Hughes and Xavier Robert, all of whom collectively share the power to vote and dispose of the securities beneficially owned by ECP ControlCo, LLC. As a result of these relationships, each of the foregoing entities and individuals may be deemed to share beneficial ownership of the securities held of record by Hill City. Each such entity and individual disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein.

The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $12.92 to $13.30. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Due to filing limitations of the electronic filing system, each of ECP ControlCo, LLC, Energy Capital Partners IV, LLC, Energy Capital Partners GP IV, LP, Energy Capital Partners IV-A, LP, Energy Capital Partners IV-B, LP, Energy Capital Partners IV-C, LP, Energy Capital Partners IV-D, LP and Energy Capital Partners IV-B (Hill City IP), LP are filing a separate Form 4.


Due to filing limitations of the electronic filing system, each of ECP Fiber Holdings GP, LLC, ECP Fiber Holdings, LP, Hill City Holdings GP, LLC and Hill City Holdings, LP are filing a separate Form 4.


Kiniksa Pharmaceuticals International, plc

Class A Ordinary Share

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 3, 2024.

The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is March 16, 2021.


Class A Ordinary Share

The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of January 16, 2025 to July 15, 2025. The acquisition of these shares was exempt pursuant to Rule 16b-3(e).

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024.

This transaction was executed in multiple trades through a broker-dealer at prices ranging between $32.01 and $32.895. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is March 13, 2020.


Shares beneficially owned directly by Braeside Capital, L.P. ("Braeside Capital").   Braeside Investments, LLC ("Braeside Investments") serves as the investment manager of Braeside Capital. As a co-manager of Braeside Investments, Mr. Stein may be deemed to beneficially own the shares beneficially owned directly by Braeside Capital. Mr. Stein disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

Shares beneficially owned directly by a proprietary account under Braeside Investments, LLC.  Braeside Investments, LLC ("Braeside Investments") serves as the investment manager of Braeside Capital, L.P. and Braeside Capital II, L.P.  As a co-manager of Braeside Investments, Mr. Stein may be deemed to beneficially own the shares beneficially owned directly by Braeside Investments.   Mr. Stein disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

Shares beneficially owned directly by Braeside Capital II, L.P. ("Braeside Capital II").  Braeside Investments serves as the investment manager of Braeside Capital II. As a co-manager of Braeside Investments, Mr. Stein may be deemed to beneficially own the shares beneficially owned directly by Braeside Capital II. Mr. Stein disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.


Common Stock

Each Restricted Stock Units ("RSUs") represents a contingent right to receive one share of the issuer's Common Stock.


The sales were executed in multiple trades at prices ranging from $54.00-$54.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.

The sales were executed in multiple trades at prices ranging from $55.00-$55.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.

Following all the transactions reported on this Form 4, the reporting person holds 352,890 shares directly.

Following all the transactions reported on this Form 4, the reporting person holds 0 shares indirectly through the issuer's 401(k) plan as of August 6, 2025.


Common stock

The reported transactions were completed pursuant to a trading plan entered into by Mr. Lucareli on November 7, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.  This completes all activity under that plan.

This total includes 971 units of Modine common stock held in the Reporting Person's Modine 401(k) Retirement Plan account.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.21 to $141.01, inclusive. The reporting person undertakes to provide to Modine Manufacturing Company, any security holder of Modine Manufacturing Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.31 to $141.83, inclusive.


Common Stock

Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

/s/ Susan Eylward, Attorney-in-Fact for Khursheed Anwer


Common Stock

The Pre-Funded Warrants have no expiration date and are exercisable immediately. Notwithstanding the foregoing, the Reporting Persons shall not be entitled to exercise the Pre-Funded Warrants to the extent that it would cause the aggregate number of shares of Common Stock beneficially owned by the Reporting Persons, together with their Attribution Parties (as defined in the Pre-Funded Warrants), to exceed 9.99% of the total number of issued and outstanding shares of Common Stock of the Issuer
following such exercise.

Held by certain affiliated funds managed by RTW Investments, LP ("RTW"). Roderick Wong, M.D. serves as the Managing Partner and Chief Investment Officer of RTW. The Reporting Persons disclaim beneficial ownership of the reported securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, except to the extent of their pecuniary interest therein.


Singisetti Ravi Kumar

C/O COGNIZANT TECHNOLOGY SOLUTIONS CORP.

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.00 to $71.09, inclusive. The reporting person undertakes to provide to Cognizant Technology Solutions Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

/s/ Kelli Arman, on behalf of Ravi Kumar Singisetti, by Power of Attorney


Common Stock

These shares of common stock reflect the settlement of restricted stock units of the Issuer. Each Restricted Stock Unit (RSU) is convertible into a share of common stock on a 1-for-1 basis.

Represents the number of shares withheld upon vesting of restricted stock units to cover tax withholding obligations.

The Restricted Stock Units granted on August 5, 2024 vest in twelve (12) quarterly installments beginning on November 5, 2024 and ending on August 5, 2027 and will be settled into shares of common stocks on or following the vesting dates.

If the reporting person's employment is terminated for any reason before an applicable Vesting Date, all restricted stock units that have not yet vested shall be forfeited without consideration, except as provided in the change of control severance agreement and any other agreements regarding equity vesting and exercisability between the reporting person and Issuer, which agreements or form agreements are filed with the SEC.

/s/ Stan Finkelstein, Attorney-in-fact for Mike Slessor


/s/ Kelli Arman, on behalf of Surya Gummadi, by Power of Attorney


Common Stock

/s/ Susan Eylward, Attorney-in-Fact for Michael Tardugno


The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 20, 2024.

The price reported in column 4 is a weighted average price. The shares were acquired in multiple transactions at prices ranging from $1.68 to $1.77, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

The reporting person owns the securities indirectly through GOHO, LLC, of which Mr. Goldsteen is the sole managing member. Mr. Goldsteen disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.

The price reported in column 4 is a weighted average price. The shares were acquired in multiple transactions at prices ranging from $1.72 to $1.76, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

The price reported in column 4 is a weighted average price. The shares were acquired in multiple transactions at prices ranging from $1.70 to $1.79, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

/s/ John Carpenter, Power of Attorney for Mitchell B. Goldsteen


Common Stock

If the reporting person's employment is terminated for any reason before an applicable Vesting Date, all restricted stock units that have not yet vested shall be forfeited without consideration, except
as provided in the change of control severance agreement and any other agreements regarding equity vesting and exercisability between the reporting person and Issuer, which agreements or form
agreements are filed with the SEC.

/s/: Stan Finkelstein, Attorney-in-fact for Shai Shahar


Represents shares surrendered by the Reporting Person to cover tax liability associated with the vesting of a grant to the Reporting Person pursuant to the PureCycle Technologies, Inc. 2021 Equity and Incentive Compensation Plan.

Brad S. Kalter as attorney-in-fact for Dustin Olson


By the William Lewis Family Legacy Trust

Common Stock

This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

This is the weighted average sales price representing 1,693 shares sold at prices ranging from $108.24 to $109.23 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

This is the weighted average sales price representing 3,199 shares sold at prices ranging from $109.25 to $110.23 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

This is the weighted average sales price representing 1,938 shares sold at prices ranging from $110.26 to $111.24 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

/s/ William Lewis, by Michael A. Smith as Attorney-in-fact


On August 4, 2025, the reporting person was granted 1,290 shares of restricted stock. The restrictions will lapse on July 31, 2026.

/s/ Scott M. Wilson as Attorney-in-Fact for Richard Beckwitt


Common stock

Mr. Osterer shares voting and dispositive power over such securities.

One-third of the options vested and became exercisable on each of 8/6/19, 8/6/20 and 8/6/21 (the first, second and third anniversaries of the grant date).


Common Stock

Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

/s/ Susan Eylward, Attorney-in-Fact for Stacy Lindborg


On August 4, 2025, the reporting person was granted 1,173 shares of restricted stock. The restrictions will lapse on July 31, 2026.

/s/ Scott M. Wilson as Attorney-in-Fact for George John Damiris


Represents the weighted average price of shares sold at prices that ranged from $91.91 to $92.07. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

The shares were sold pursuant to a Rule 10b-5 trading plan adopted by the Reporting Person on March 7, 2025.

Represents the weighted average price of shares sold at prices that ranged from $91.51 to $92.33. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Represents the weighted average price of shares sold at prices that ranged from $92.64 to $93.42. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Represents the weighted average price of shares sold at prices that ranged from $91.56 to $91.85. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Represents the weighted average price of shares sold at prices that ranged from $91.09 to $92.07. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Represents the weighted average price of shares sold at prices that ranged from $92.10 to $92.47. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.


Common stock

Mr. Mohr shares voting and dispositive power over such securities.


Common Stock

This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

/s/ Martina Flammer, M.D., by Michael A. Smith as Attorney-in-fact


Represents the weighted average sale price of $268.63 rounded to the nearest hundredth. The highest price at which the shares were sold was $269.24 and the lowest price at which the shares were sold was $268.19. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.


/s/ Scott M. Wilson as Attorney-in-Fact for Mauro Gregorio


Represents number of securities owned by EN Holdings LLC, which is owned by the reporting person and his affiliates.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.87 to $64.75. The Reporting Person undertakes to provide Interactive Brokers Group, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) - (4) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.32 to $64.31.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.32 to $65.05.

This amount includes (a) Class A common stock attributable to vested restricted stock units that were awarded under the amended 2007 Stock Incentive Plan ("Plan") and (b) unvested restricted stock units that were awarded under the Plan.

/s/ Raymond Bussiere as authorized signatory for Earl H. Nemser


Represents the weighted average price of shares sold at prices that ranged from $91.39 to $91.40. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.


Consists of shares of Class A restricted common stock.

Includes shares of Class A restricted common stock.

By: /s/ Jacob D. Bernstein, as Attorney-in-Fact for Joan Lordi Amble


By: /s/ Jamie Weatherby, as Attorney-in-Fact for Robert C. O'Brien


The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2024.

Represents shares withheld to cover tax withholding obligations upon the settlement of a previously reported performance-based restricted stock unit award.

/s/ Marv Gurevich, Esq., as attorney-in-fact for Christopher J. McKay


By Michele Angelique Flournoy Living Trust

By: /s/ Jacob D. Bernstein, as Attorney-in-Fact for Michele A. Flournoy


By: /s/ Jamie Weatherby, as Attorney-in-Fact for Debra L. Dial


By: /s/ Jamie Weatherby as Attorney-in-Fact for William McClellan Thornberry


Martin Product Sales LLC ("Martin Product"), is a wholly owned subsidiary of Martin Resource Management Corporation ("MRMC"), and therefore, MRMC may be deemed to beneficially own the common units (the "Common Units") representing limited partner interests in Martin Midstream Partners L.P. (the "Partnership") held by Martin Product. Following the transaction, MRMC will directly or indirectly own 7,660,461.23 Common Units, including the Common Units directly held by Martin Product, and has control of the general partner of the Partnership by virtue of its owning 100% of the equity interests of the sole member of the Partnership's general partner.

/s/ Sharon L. Taylor, Executive Vice President and Chief Financial Officer


By: /s/ Jacob D. Bernstein, as Attorney-in-Fact for Mark Gaumond


The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2025.

/s/ Marv Gurevich, Esq., as attorney-in-fact for Pamela D. Johnson


By: /s/ Jacob D. Bernstein, as Attorney-in-Fact for Charles O. Rossotti


By: /s/ Jacob D. Bernstein, as Attorney-in-Fact for Rory P. Read


By: /s/ Jacob D. Bernstein, as Attorney-in-Fact for Gretchen W. McClain


On August 4, 2025, the reporting person was granted 1,290 shares of restricted stock. The restrictions will lapse on July 31, 2026.

/s/ Scott M. Wilson as Attorney-in-Fact for Martin M. Ellen


By: /s/ Jacob D. Bernstein, as Attorney-in-Fact for Arthur E. Johnson


By: /s/ Jacob D. Bernstein, as Attorney-in-Fact for Ellen Jewett


Pursuant to Company policy, market transactions in Company stock by officers and directors are permitted only after the first full trading day after the release of quarterly earnings and ending on the fourteenth day of the third month of
the following fiscal quarter, except pursuant to approved 10b5-1 trading plans.

The transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 14, 2024.

Includes shares acquired pursuant to NIKE, Inc.'s Employee Stock Purchase Plan.

Shares held in account under the NIKE, Inc. 401(k) Savings and Profit Sharing Plan.

/s/ Carlos J. Wilson, attorney-in-fact for Mr. Leinwand


Class A Common Stock

Class A Common Stock

Represents the conversion of Class B Common Stock held of record by The Brian Armstrong Living Trust into Class A Common Stock.

The transactions reported on this line were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2024, during an open trading window.

Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

Represents the weighted average sale price. The lowest price at which shares were sold was $314.67 and the highest price at which shares were sold was $315.66. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (4) through (9) to this Form 4.

Represents the weighted average sale price. The lowest price at which shares were sold was $315.67 and the highest price at which shares were sold was $316.66.

Represents the weighted average sale price. The lowest price at which shares were sold was $316.67 and the highest price at which shares were sold was $317.66.

Represents the weighted average sale price. The lowest price at which shares were sold was $317.67 and the highest price at which shares were sold was $318.65.

Represents the weighted average sale price. The lowest price at which shares were sold was $318.68 and the highest price at which shares were sold was $319.66.

Represents the weighted average sale price. The lowest price at which shares were sold was $319.71 and the highest price at which shares were sold was $319.87.

These shares are held by The Ehrsam 2014 Irrevocable Trust, of which the Reporting Person is trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.

/s/ Brian Armstrong, by Lailey Rezai, Attorney-in-Fact


The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.94 to $23.40, inclusive. The reporting person undertakes to provide to Universal Insurance Holdings, Inc., any security holder of Universal Insurance Holdings Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1).


This transaction was executed in multiple trades at prices ranging from $31.56 to $31.72; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

/s/ Martijn van Steenpaal, as Attorney-in-Fact for Randall C. Stuewe


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.03 to $13.47, inclusive.

Includes 28,606 restricted stock units ("RSUs") granted on December 27, 2024 to non-employee directors for board service. The RSUs represent a contingent right to receive shares of common stock of Applied Digital Corporation on a one-for-one basis, have no expiration date, and vest in full on November 20, 2025, subject to the Reporting Person's continued service through such date.


On August 4, 2025, the reporting person was granted 561 shares of restricted stock. The restrictions will lapse on July 31, 2026.

/s/ Scott M. Wilson as Attorney-in-Fact for Margot Lebenberg Carter


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.55 to $167.54, inclusive. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.545 to $168.13, inclusive. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.


Ordinary Shares

These restricted stock units were granted on August 4, 2022 and vested as follows: 33% on the first and second anniversary of the grant date and the remaining 34% on the third anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.

This field is not applicable.

Chief Executive Officer of Eaton Corporation, a subsidiary of the Issuer. Power of Attorney is attached hereto as Exhibit 24.


Represents shares underlying restricted stock units ("RSUs") surrendered to satisfy the reporting person's tax withholding obligation upon vesting of the RSUs. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3(e).

/s/ Stacy S. Ingram, by Power of Attorney


Class A Common Stock

Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date.

/s/ Lindsey Cochran, by power of attorney


Common Stock

Common Stock

Convertible Notes are convertible at the option of Lancer Capital into shares of the Company's common stock at the conversion rate of $42.3143.

On August 4, 2025, pursuant to that Exchange Agreement dated as of July 17, 2025 by and be-tween Lancer Capital LLC ("Lancer Capital") and the Company, Lancer Capital exchanged $2.0 million in principal amount of the Company's 7.5% Convertible Senior Notes due 2026 (the "Old Convertible Notes"), together with all interest accrued and unpaid thereon, for $2.195 million in principal amount of the Company's 9.5% Convertible Senior Notes due 2027 (the "New Convertible Notes"). The Old Convertible Notes were convertible at the option of Lancer Capital into shares of the Company's common stock at any time until their maturity date (August 1, 2026) at the conversion rate of $42.3143, subject to anti-dilution adjustment. The New Convertible Notes are convertible at the option of Lancer Capital into shares of the Company's common stock at any time until their maturity date (March 1, 2027) at the conversion rate of $42.3143, subject to ant-dilution adjustment.

The reported shares are directly beneficially owned by Lancer Capital. The Avram Glazer Irrevocable Exempt Trust (the "Trust") is the sole member of Lancer Capital, and in such capacity may be deemed to beneficially own the shares beneficially owned by Lancer Capital. Mr. Avram A. Glazer is the trustee of the Trust, and in such capacity may be deemed to beneficially own the shares beneficially owned by the Trust.

Mrs. Jill H. Glazer is the spouse of Mr. Glazer and in such capacity may be deemed to beneficially own the shares beneficially owned by him.


On August 4, 2025, the reporting person was granted 1,173 shares of restricted stock. The restrictions will lapse on July 31, 2026.

/s/ Scott M. Wilson as Attorney-in-Fact for David Rush


The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.


Class A Common Stock

Class A Common Stock

Class A  Common Stock

Class A Common Stock

Class A Common Stock

Represents the exercise of options to purchase common stock by the reporting person's spouse. No shares were sold by the reporting person or the reporting person's spouse, and the shares received upon the exercise of such options are subject to a lock-up agreement with the underwriters for the Company's recent initial public offering

The stock option is fully vested and currently exercisable.


/s/ Jason Bartel, attorney-in-fact for Mr. Gallagher


/s/ Scott M. Wilson as Attorney-in-Fact for Mary P. Ricciardello


$45.9711. The price reported is a weighted average price. The shares were sold in multiple transactions with prices ranging from $45.9710 to $45.98. The reporting person undertakes to provide to OGE Energy, any security holder of OGE Energy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted herein.

The information herein is based on a Retirement Savings Plan Statement dated August 4, 2025. The Retirement Savings Plan Statement indicated the number of shares in the Common Stock Fund of the Retirement Savings Plan credited to the participant's account at August 4, 2025 and includes shares credited since reporting person's last table 1 filing that was exempt from reporting pursuant to Rule 16A-3(f)(1)(i)(B).

/s/ William Sultemeier, By Power of Attorney


Includes 28,606 restricted stock units ("RSUs") granted on December 27, 2024 to non-employee directors for board service. The RSUs represent a contingent right to receive shares of common stock of Applied Digital Corporation (the "Issuer") on a one-for-one basis, have no expiration date, and vest in full on November 20, 2025, subject to the Reporting Person's continued service through such date.

Includes 200,000 shares of restricted stock granted to the Reporting Person on May 13, 2024 in connection with the Reporting Person's service as the Chairman of the board of directors of Applied Digital Cloud Corporation, a subsidiary of the Issuer. The shares of restricted stock vest as follows: 100,000 shares on May 13, 2026 (the second anniversary of the grant date) and 100,000 shares on May 13, 2027 (the third anniversary of the grant date), provided that the Reporting Person is a director of both the Issuer and Applied Digital Cloud Corporation on each such date.


By Profit Sharing Plan of Reporting Person's Employer

On August 4, 2025, the reporting person was granted 1,902 shares of restricted stock. The restrictions will lapse on July 31, 2026.

/s/ Scott M. Wilson as Attorney-in-Fact for Michael R. Nicolais


Common Stock

Holdings are Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on August 4, 2026, with the remaining shares vesting in equal quarterly installments over the following two years.

This option represents a right to purchase a total of 554,071 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on August 4, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.

/s/ Martin Wilson, as attorney-in-fact for Christopher James Stevens


Represents the disposition of shares to the company to cover taxes on the vesting of awards.

Balance includes shares of common stock acquired by the reporting person from participation in the company's employee stock purchase plan and through dividend reinvestment.

/s/ Dara Steele-Belkin, attorney-in-fact for Robert M. Cortopassi


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.300 to $21.305, inclusive.

/s/ Emmanuelle Lee, attorney-in-fact for Loic Eloy


Common Stock

The option vests and becomes exercisable in four equal quarterly installments occurring on August 5, 2026, August 5, 2027, August 5, 2028, August 5, 2029, subject to the reporting person continuing in service on the Board as a non-employee director through the applicable vesting date.

/s/ Thomas J. DesRosier, Attorney-in-Fact for Robert L. Rosiello


The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan that was adopted on November 25, 2024.

Certain of these securities are represented by restricted stock units.

The shares are held by The Still Family Trust U/A DTD 08/18/2008 for which the Reporting Person serves as co-trustee.

/s/ Kimberly Hackman, by power of attorney


Common Stock

Restricted stock units convert into common stock on a one-for-one basis.

These restricted stock units vest in a single installment on August 4, 2025.

/s/ Heather Enlow-Novitsky as Attorney-in-Fact for Jason Bengel


Shares issued pursuant to the Director's elected form of compensation for quarterly annual retainer.

Robert S. Molloy, Attorney-in-Fact for Elaine Rubin


Shares issued pursuant to the Director's elected form of compensation for quarterly annual retainer and committee chairperson fee.

Robert S. Molloy, Attorney-in-Fact for Ivy Ross


Common Stock

The Reporting Person's ownership includes (i) 420,286 shares held by the Mesdag Family Limited Partnership, (ii) 97,529 shares held by the Mesdag Family Foundation, (iii) 44,746 shares held by the 2012 Mesdag Trust, (iv)  1,763,373 shares held by Red Mountain Capital Partners LLC, and (v) 267,824 shares held by Red Mountain Capital Management Inc.  The Reporting Person is the president, sole executive officer, sole director and sole shareholder of Red Mountain Capital Management Inc.  The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein. The filing system would not permit the filer to report his ownership as indirect.

Deferred Stock Units (DSUs) issued pursuant to the Director's elected form of compensation for quarterly annual retainer and committee chairperson fee.

The per share value is determined by the closing price of the Company's common stock on August 1, 2025.

Each DSU is credited to the Reporting Person under the Company's Director Plan (the "Director Plan").  Each DSU represents ownership equivalent to one share of the Company's common stock.

The DSUs credited under the Director Plan are payable in the form elected or provided under the Director Plan on the earlier of (i) the Reporting Person's date of separation of service, or (ii) upon death, disability or change in control as defined under the Director Plan.

/s/ Willem Mesdag (on behalf of himself and the other Reporting Persons)


Common Shares

Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.

This option vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd, and 3rd anniversaries of the grant date, subject to the Reporting Person's continuous service as of each vesting date.

/s/ Tuan Nguyen as attorney-in-fact for Roger Sawhney


Robert S. Molloy, Attorney-in-Fact for Jack Boyle


Robert S. Molloy, Attorney-in-Fact for Carmen R. Bauza


Includes 28,606 restricted stock units ("RSUs") granted on December 27, 2024 to non-employee directors for board service. The RSUs represent a contingent right to receive shares of common stock of Applied Digital Corporation on a one-for-one basis, have no expiration date, and vest in full on November 20, 2025, subject to the Reporting Person's continued service through such date.


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

On December 5, 2022, Mr. Sherman was granted 249,169 stock options. The options vest ratably over four years with the first tranche vesting on December 7, 2023.

On May 11, 2023, Mr. Sherman was granted 73,016 stock options. The options vest ratably over the first three anniversary dates of the grant date.

On May 11, 2023, Mr. Sherman was granted 39,016 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.

Once vested, the shares of common stock are not subject to expiration.

On May 11, 2023, Mr. Sherman was granted 39,016 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 58,524. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.

On February 23, 2024, Mr. Sherman was granted 77,913 stock options. The options vest ratably over the first three anniversary dates of the grant date.

On February 23, 2024, Mr. Sherman was granted 46,606 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 69,910. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.

On February 23, 2024, Mr. Sherman was granted 46,606 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.

This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.

On February 21, 2025, Mr. Sherman was granted 214,900 stock options. The options vest ratably over the first three anniversary dates of the grant date.

On February 21, 2025, Mr. Sherman was granted 126,476 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.


Common Stock

The Employee Stock Options in this grant are fully vested and expire in 2026.

/s/ Kira Schwartz, attorney in fact for Mohamed Ali


Amended and Restated Anthony P. Zook Living Trust

Common Stock

Common Stock

Common Stock

Common Stock

This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%.

On April 1, 2025, Mr. Zook was granted 729,927 stock options. The options vest ratably over the first three anniversary dates of the grant date.

On April 1, 2025, Mr. Zook was granted 421,496 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.


Relationship of Reporting Person to Issuer: Edison Energy, LLC dba Trio is a subsidiary of Edison International.

This transaction was executed in multiple trades at prices ranging from $54.41 to $54.44. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and the separate prices at which the transaction was effected.


Represents the disposition of shares to the company to cover taxes on the vesting of awards.

/s/ Dara Steele-Belkin, attorney-in-fact for Joshua J. Whipple


Common Stock

Restricted stock units convert into common stock on a one-for-one basis.

The shares subject to this restricted stock unit award vested in full on August 5, 2025.


Represents Restricted Stock Units ("RSUs") that will vest over an approximately four year period.  1/4 of the RSUs subject to this award will vest on September 1, 2027 and 1/8th of the RSUs shall vest in equal quarterly increments thereafter.


The Reporting Person received 2,094 restricted stock units equal to $155,000 divided by the closing stock price of $74.04 on August 5, 2025, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.

/s/ John F. Kelly by Christine Sacco Attorney-in-Fact pursuant to Power of Attorney dated May 8, 2017 on file with the Commission


Common Stock

The shares underlying this option are fully vested and exercisable as of the date hereof.


Common Stock

Represents the weighted average of a range of sale prices from $88.50 to $88.94. The reporting person undertakes to provide to the Staff of the Securities and Exchange Commission, the Company, or any stockholder of the Company, upon request, full information regarding the number of shares sold at each separate price.

Received as employment compensation

/s/ Michael Peterson by Diane Gallagher, attorney-in-fact


Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

/s/  Kendra Fox, as Attorney-in-Fact for Robert F. Werner


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

The option is immediately exercisable.  25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

Represents performance stock options granted to the reporting person on September 1, 2020, that vested and became exercisable on December 19, 2022 as a result of the reporting person having met the applicable performance criteria.

/s/ Kendra Fox, as Attorney-in-Fact for Emily M. Leproust


/s/ Kendra Fox, as Attorney-in-Fact for Paula Green


Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by
the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by
the Reporting Person.

Senior Vice President, Chief Legal Officer & Corporate Secretary

/s/ Kendra Fox, as Attorney-in-Fact for Dennis Cho


/s/ Kendra Fox, as Attorney-in-Fact for Patrick John Finn


The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on February 26, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.83 to $128.995. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.00 to $129.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.00 to $130.66. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024.


/s/ Dawn M. Zier by Christine Sacco Attorney-in-Fact pursuant to Power of Attorney dated May 4, 2020 on file with the Commission


/s/ Shelia A. Hopkins by Christine Sacco Attorney-in-Fact pursuant to Power of Attorney Dated May 8, 2017 on file with the Commission


Class A Common Stock

Class A Common Stock

After giving effect to the transactions reported herein, this represents (i) 7,417 shares of Class A common stock and 1,026,190 shares of Class B common stock held by the JRH Revocable Trust, of which the Reporting Person serves as the sole trustee; (ii) 170,000 shares of Class B common stock held by the EEH Revocable Trust, of which the Reporting Person's spouse serves as the sole trustee; (iii) 285,000 shares of Class B common stock held by the JRH Gift Trust, of which the Reporting Person's spouse serves as the sole trustee; and (iv) 300,000 shares of Class B common stock held by the EEH Gift Trust, of which the Reporting Person serves as the sole trustee.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.19 to $16.64 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The total reported in column 5 includes: (1) 18,462 reported RSUs which vest in 3 equal quarterly installments beginning on September 1, 2025; (2) 49,774 reported RSUs of which vest in 7 equal quarterly installments beginning on September 1, 2025; (3) 81,623 reported RSUs which vest in 11 equal quarterly installments beginning on September 1, 2025; and (4) 109,489 reported RSUs of which 25% will vest on March 1, 2026 with the remaining RSUs vesting in 12 equal quarterly installments beginning on June 1, 2026. Each RSU represents the contingent right to receive one share of Class A Common Stock of the Issuer and does not expire.

Shares of Class B Common Stock have no economic rights and each share entitles its holder to 10 votes per share. Each share of Class B Common Stock is exchangeable by the holder on a one-for-one basis for Class A Common Stock at any time and does not expire.

The transactions reported in this Form 4 occurred under a 10b5-1 plan adopted by the Reporting Person on September 10, 2024.

/s/ Heidi Jonas, Attorney-in-fact for Justyn R. Howard


The transaction was effected pursuant to a pre-planned trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The pre-planned trading plan was adopted by the reporting person for personal financial management purposes on May 5, 2025.

This transaction was executed in multiple trades at prices ranging from $563.00 to $563.90. The price reported reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Reflects 35.978 shares of Class A Common Stock acquired by the reporting person in May 2025 pursuant to the company's Employee Stock Purchase Plan.

This transaction was executed in multiple trades at prices ranging from $564.09 to $564.97. The price reported reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades at prices ranging from $565.10 to $566.08. The price reported reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades at prices ranging from $566.15 to $567.11. The price reported reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades at prices ranging from $567.23 to $568.22. The price reported reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades at prices ranging from $568.33 to $568.91. The price reported reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades at prices ranging from $569.80 to $570.05. The price reported reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Exhibit 24: Power of Attorney is attached.

/s/ Craig Brown, as attorney-in-fact for Sachin Mehra pursuant to a power of attorney dated July 14, 2025


Common Stock

This includes an aggregate of 32,544 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested.

Beginning October 2, 2023, options become exercisable in 37 installments, with the first 25% vesting on October 2, 2024 and the remainder vesting monthly over three years.


The Reporting Person received 2,094 restricted stock units equal to $155,000 divided by the closing stock price of $674.04 on August 5, 2025, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.

/s/ James C. D'Arecca by Christine Sacco Attorney-in-Fact pursuant to Power of Attorney dated July 5, 2023 on file with the Commission


The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.19 to $16.64 per share, inclusive. The Reporting Person
undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each
separate price within the range set forth in this footnote.

The total reported in column 5 includes: (1) 6,574 reported RSUs which vest in 3 equal quarterly installments beginning on September 1, 2025; (2) 17,777 reported RSUs which vest in 7 equal
quarterly installments beginning on September 1, 2025; (3) 37,897 reported RSUs which vest in 11 equal quarterly installments beginning on September 1, 2025; and (4) 118,613 reported RSUs of which
25% will vest on March 1, 2026 with the remaining RSUs vesting in 12 equal quarterly installments beginning on June 1, 2026. Each RSU represents the contingent right to receive one share of Class A
Common Stock of the Issuer and does not expire.

The transaction in this Form 4 occurred under a 10b5-1 plan adopted by the Reporting Person on August 20, 2024.

/s/ Heidi Jonas, Attorney-in-fact for Joseph Del Preto


Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number
of common shares of the Issuer: (i) 14,926 RSUs scheduled to vest on July 3, 2026; (ii)
29,632 RSUs scheduled to vest in two equal annual installments on July 1, 2026 and 2027; and (iii)
8,982 RSUs scheduled to vest in three equal installments on August 4, 2026, 2027 and 2028.

/s/ Audrey Lee, by power of atty., for Scott Macdonald


Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number
of common shares of the Issuer: (i) 7,071 RSUs scheduled to vest on July 3, 2026; (ii)
13,770 RSUs scheduled to vest in two equal annual installments on July 1, 2026 and 2027; and (iii)
6,196 RSUs scheduled to vest in three equal installments on August 4, 2026, 2027 and 2028.


Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number
of common shares of the Issuer: (i) 21,843 RSUs scheduled to vest on July 3, 2026; (ii)
41,298 RSUs scheduled to vest in two equal annual installments on July 1, 2026 and 2027; and (iii) 13,531 RSUs scheduled to vest in three equal installments on August 4, 2026, 2027 and 2028.

/s/ Audrey Lee, by power of atty., for Alison Hoffman


The Reporting Person received 2,094 restricted stock units equal to $155,000 divided by the closing stock price of $74.04 on August 5, 2025, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.

/s/ Celeste Clark by Christine Sacco Attorney-in-Fact pursuant to Power of Attorney dated May 4, 2021 on file with the Commission


Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number
of common shares of the Issuer: (i) 4,010 RSUs scheduled to vest on July 3, 2026; (ii) 9,086
RSUs scheduled to vest in two equal annual installments on July 1, 2026 and 2027; and (iii) 4,672 RSUs scheduled to vest in three equal annual installments on August 4, 2026, 2027 and 2028.

/s/ Audrey Lee, by power of atty., for Jason Wyrick